Showing results (1851-1860 of 2,092) with videos related to
Sort By:
Pageof 210
International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastasesEric L Chang, Almon S Shiu, Ming-Fwu Lii, et al.International Journal of Peptide and Protein Research|April 1, 1996
Isolation and characterization of a trisulfide variant of recombinant human growth hormone formed during expression in Escherichia coliC Andersson, P O Edlund, P Gellerfors, et al.Frontiers in Immunology|March 2, 2026
Risk stratification by donor-derived cell-free DNA: a three-year single center study of kidney transplant outcomes from 257 patientsRhys Mendel, Kabir Jalal, Lin Liu, et al.Antimicrobial Agents and Chemotherapy|March 6, 2013
Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary tuberculosisAndreas H Diacon, Rodney Dawson, Florian Von Groote-Bidlingmaier, et al.Acta Haematologica|November 29, 2022
A Co-Management Model for Myeloid Malignancies That Evolved during the COVID-19 PandemicNiyati Goradia, Aditi Shastri, Amit Verma, et al.World Neurosurgery|December 25, 2023
Racial/Ethnic Disparities Among Patients Undergoing Anterior Cervical Discectomy and Fusion or Posterior Cervical Decompression and Fusion for Cervical Spondylotic Myelopathy: A National Administrative Database AnalysisAladine A Elsamadicy, Sumaiya Sayeed, Josiah J Z Sherman, et al.ACS Pharmacology & Translational Science|December 21, 2020
Heterodimeric Insecticidal Peptide Provides New Insights into the Molecular and Functional Diversity of Ant VenomsAxel Touchard, Helen C Mendel, Isabelle Boulogne, et al.Experimental Hematology & Oncology|January 5, 2021
Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AMLSakshi Jasra, Mohammed Kazemi, Nishi Shah, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignanciesCheryl A London, Alison L Hannah, Regina Zadovoskaya, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2021
Influenza Vaccination in Health Centers During the Coronavirus Disease 2019 Pandemic-United States, 7-27 November 2020Suzanne M Marks, Alexey Clara, Amy Parker Fiebelkorn, et al.Pageof 210